In the News September 11, 2018

The Pink Sheet | Could US Solve Drug Shortages with ‘Heightened’ M&A Scrutiny?

Marc Scheineson comments on a plan by the Food and Drug Administration to prevent drug shortages by examining pharma company mergers and acquisitions.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement